Cargando…

Short term results of vaccination with adjuvanted recombinant varicella zoster glycoprotein E during initial BTK inhibitor therapy for CLL or lymphoplasmacytic lymphoma

Detalles Bibliográficos
Autores principales: Zent, Clive S., Brady, Michael T., Delage, Carolyne, Strawderman, Myla, Laniewski, Nathan, Contant, Phuong N., Kanagaiah, Preshetha, Sangster, Mark Y., Barr, Paul M., Chu, Charles C., Topham, David J., Friedberg, Jonathan W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596619/
https://www.ncbi.nlm.nih.gov/pubmed/33128020
http://dx.doi.org/10.1038/s41375-020-01074-4
_version_ 1783602152529199104
author Zent, Clive S.
Brady, Michael T.
Delage, Carolyne
Strawderman, Myla
Laniewski, Nathan
Contant, Phuong N.
Kanagaiah, Preshetha
Sangster, Mark Y.
Barr, Paul M.
Chu, Charles C.
Topham, David J.
Friedberg, Jonathan W.
author_facet Zent, Clive S.
Brady, Michael T.
Delage, Carolyne
Strawderman, Myla
Laniewski, Nathan
Contant, Phuong N.
Kanagaiah, Preshetha
Sangster, Mark Y.
Barr, Paul M.
Chu, Charles C.
Topham, David J.
Friedberg, Jonathan W.
author_sort Zent, Clive S.
collection PubMed
description
format Online
Article
Text
id pubmed-7596619
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-75966192020-10-30 Short term results of vaccination with adjuvanted recombinant varicella zoster glycoprotein E during initial BTK inhibitor therapy for CLL or lymphoplasmacytic lymphoma Zent, Clive S. Brady, Michael T. Delage, Carolyne Strawderman, Myla Laniewski, Nathan Contant, Phuong N. Kanagaiah, Preshetha Sangster, Mark Y. Barr, Paul M. Chu, Charles C. Topham, David J. Friedberg, Jonathan W. Leukemia Letter Nature Publishing Group UK 2020-10-30 2021 /pmc/articles/PMC7596619/ /pubmed/33128020 http://dx.doi.org/10.1038/s41375-020-01074-4 Text en © The Author(s), under exclusive licence to Springer Nature Limited 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Letter
Zent, Clive S.
Brady, Michael T.
Delage, Carolyne
Strawderman, Myla
Laniewski, Nathan
Contant, Phuong N.
Kanagaiah, Preshetha
Sangster, Mark Y.
Barr, Paul M.
Chu, Charles C.
Topham, David J.
Friedberg, Jonathan W.
Short term results of vaccination with adjuvanted recombinant varicella zoster glycoprotein E during initial BTK inhibitor therapy for CLL or lymphoplasmacytic lymphoma
title Short term results of vaccination with adjuvanted recombinant varicella zoster glycoprotein E during initial BTK inhibitor therapy for CLL or lymphoplasmacytic lymphoma
title_full Short term results of vaccination with adjuvanted recombinant varicella zoster glycoprotein E during initial BTK inhibitor therapy for CLL or lymphoplasmacytic lymphoma
title_fullStr Short term results of vaccination with adjuvanted recombinant varicella zoster glycoprotein E during initial BTK inhibitor therapy for CLL or lymphoplasmacytic lymphoma
title_full_unstemmed Short term results of vaccination with adjuvanted recombinant varicella zoster glycoprotein E during initial BTK inhibitor therapy for CLL or lymphoplasmacytic lymphoma
title_short Short term results of vaccination with adjuvanted recombinant varicella zoster glycoprotein E during initial BTK inhibitor therapy for CLL or lymphoplasmacytic lymphoma
title_sort short term results of vaccination with adjuvanted recombinant varicella zoster glycoprotein e during initial btk inhibitor therapy for cll or lymphoplasmacytic lymphoma
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596619/
https://www.ncbi.nlm.nih.gov/pubmed/33128020
http://dx.doi.org/10.1038/s41375-020-01074-4
work_keys_str_mv AT zentclives shorttermresultsofvaccinationwithadjuvantedrecombinantvaricellazosterglycoproteineduringinitialbtkinhibitortherapyforcllorlymphoplasmacyticlymphoma
AT bradymichaelt shorttermresultsofvaccinationwithadjuvantedrecombinantvaricellazosterglycoproteineduringinitialbtkinhibitortherapyforcllorlymphoplasmacyticlymphoma
AT delagecarolyne shorttermresultsofvaccinationwithadjuvantedrecombinantvaricellazosterglycoproteineduringinitialbtkinhibitortherapyforcllorlymphoplasmacyticlymphoma
AT strawdermanmyla shorttermresultsofvaccinationwithadjuvantedrecombinantvaricellazosterglycoproteineduringinitialbtkinhibitortherapyforcllorlymphoplasmacyticlymphoma
AT laniewskinathan shorttermresultsofvaccinationwithadjuvantedrecombinantvaricellazosterglycoproteineduringinitialbtkinhibitortherapyforcllorlymphoplasmacyticlymphoma
AT contantphuongn shorttermresultsofvaccinationwithadjuvantedrecombinantvaricellazosterglycoproteineduringinitialbtkinhibitortherapyforcllorlymphoplasmacyticlymphoma
AT kanagaiahpreshetha shorttermresultsofvaccinationwithadjuvantedrecombinantvaricellazosterglycoproteineduringinitialbtkinhibitortherapyforcllorlymphoplasmacyticlymphoma
AT sangstermarky shorttermresultsofvaccinationwithadjuvantedrecombinantvaricellazosterglycoproteineduringinitialbtkinhibitortherapyforcllorlymphoplasmacyticlymphoma
AT barrpaulm shorttermresultsofvaccinationwithadjuvantedrecombinantvaricellazosterglycoproteineduringinitialbtkinhibitortherapyforcllorlymphoplasmacyticlymphoma
AT chucharlesc shorttermresultsofvaccinationwithadjuvantedrecombinantvaricellazosterglycoproteineduringinitialbtkinhibitortherapyforcllorlymphoplasmacyticlymphoma
AT tophamdavidj shorttermresultsofvaccinationwithadjuvantedrecombinantvaricellazosterglycoproteineduringinitialbtkinhibitortherapyforcllorlymphoplasmacyticlymphoma
AT friedbergjonathanw shorttermresultsofvaccinationwithadjuvantedrecombinantvaricellazosterglycoproteineduringinitialbtkinhibitortherapyforcllorlymphoplasmacyticlymphoma